Screener
Candel Therapeutics, Inc. CADL EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed August 13, 2026.
- Filed
- Aug 13, 2026, 8:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-347980
| Line item | THREE MONTHS ENDEDJUNE 30, 2026 | THREE MONTHS ENDEDJUNE 30, 2025 | SIX MONTHS ENDEDJUNE 30, 2026 | SIX MONTHS ENDEDJUNE 30, 2025 |
|---|---|---|---|---|
| Interest expense | (1,575) | (236) | (3,139) | (542) |
| Change in fair value of warrant liabilities | (12,278) | 5,691 | (4,635) | 20,572 |
| Total other income (expense), net | (12,159) | 6,381 | (4,736) | 21,890 |
| Net income (loss) and comprehensive income (loss) | $(38,905) | $(4,796) | $(47,766) | $2,583 |
| Net income (loss) per share, basic | $(0.52) | $(0.09) | $(0.70) | $0.05 |
| Weighted-average common shares outstanding, basic | 74,131,229 | 51,489,929 | 68,279,075 | 50,988,887 |
| Net income (loss) per share, diluted | $(0.52) | $(0.09) | $(0.70) | $0.05 |
| Weighted-average common shares outstanding, diluted | 74,131,229 | 51,489,929 | 68,279,075 | 53,369,582 |
Item 1. Financial Statements.
FAQ
- What is Candel Therapeutics, Inc.'s EPS (diluted)?
- Candel Therapeutics, Inc. (CADL) reported EPS (diluted) of -$0.52 in Q2 2026.
- How has Candel Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Candel Therapeutics, Inc.'s EPS (diluted) decreased by 477.8% year-over-year, from -$0.09 to -$0.52.
- What is the long-term trend for Candel Therapeutics, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s EPS (diluted) has grown at a 4.0% compound annual growth rate (CAGR), from -$0.64 to -$0.72.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Candel Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude